Skip to main content
logo
Bio-Rad Laboratories, Inc. (FRA:BUWA)
Germany flag Germany · Delayed Price · Currency is EUR
277.20
-1.30 (-0.47%)
Last updated: Dec 1, 2025, 8:05 AM CET

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
United States Revenue
1.04B1.04B
Log In
Log In
Log In
Upgrade
EMEA Revenue
860.90M834.10M
Log In
Log In
Log In
Upgrade
APAC Revenue
497.80M521.60M
Log In
Log In
Log In
Upgrade
Other Regional Revenue
162.00M169.30M
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.56B2.57B
Log In
Log In
Log In
Upgrade

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Life Science Revenue
1.03B1.03B
Log In
Log In
Log In
Upgrade
Clinical Diagnostics Revenue
1.53B1.54B
Log In
Log In
Log In
Upgrade
Other Segments Revenue
-500.00K
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.56B2.57B
Log In
Log In
Log In
Upgrade

Gross Profit

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Life Science Segment Profit
-582.40M
Log In
Log In
Log In
Upgrade
Clinical Diagnostics Segment Profit
-796.60M
Log In
Log In
Log In
Upgrade
Other Segments Segment Profit
--100.00K
Log In
Log In
Log In
Upgrade
Gross Profit (Total)
1.34B1.38B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Life Science Operating Profit
--
Log In
Log In
Log In
Upgrade
Clinical Diagnostics Operating Profit
--
Log In
Log In
Log In
Upgrade
Other Segments Operating Profit
--
Log In
Log In
Log In
Upgrade
Operating Income (Total)
224.40M269.00M
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.